Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes
n early 2001 there was a dramatic decline in the availability of heroin in New South Wales (NSW), Australia, where previously heroin had been readily available at a low price and high purity.1 The decline was confirmed by Australia's strategic early warning system, which revealed a reduction in heroin supply across Australia and a considerable increase in price,2 particularly from January to April 2001. This "heroin shortage" provided a natural experiment in which to examine the effect of substantial changes in price and availability on injecting drug use and its associated harms in Australia's largest heroin market,2 a setting in which harm reduction strategies were widely used. Publicly funded needle and syringe programmes were introduced to Australia in 1987, and methadone maintenance programmes, which were established in the 1970s, were significantly expanded in 1985 and again in 1999.
Year of publication: |
2004-01-01
|
---|---|
Authors: | Day, C. ; Degenhardt, L. ; Gilmour, S. ; Hall, W. |
Publisher: |
BMJ Publishing Group |
Subject: | Medicine | General & Internal | Australia |
Saved in:
freely available
Saved in favorites
Similar items by subject
-
Epidemiological modelling (including economic modelling) and its role in preventive drug therapy
Liew, D., (2002)
-
Feasibility of an evidence-based literature search service for general practitioners
Del Mar, C. B., (2001)
-
Civil Registration Systems and Vital Statistics: Successes and Missed Opportunities
Mahapatra, P., (2007)
- More ...